| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |